A highly inexpensive Alzheimer’s drug is capable of keeping late stage dementia patients out of care homes, researchers have revealed. Authors of the new study have called upon doctors to rethink their…
Tag: Drugs
Huge price hike for tuberculosis drug rescinded after public outcry
Cycloserine, an important tuberculosis drug, has had a roller coaster ride over the past few days with its prices raised to a whopping $10,800 for 30 capsules from $500. However, after a…
Diabetes drug liraglutide aids in weight loss: Study
A new study has suggested that overweight and obese type 2 diabetes patients can shed a few kilos through daily injections of drug liraglutide alongside diet and exercise regimes. The study published…
Want to control your cravings? Play Tetris
Craving for drugs, food and activities such as sex can be controlled in as little as three minutes, a research has suggested and it is as easy as playing a game. According…
Hangover costing Australian economy billions, study says
Beyond health, alcohol and drug usage is also affecting economies, as a new study has shown that alcohol and drug related (AOD) absenteeism is causing the Australian economy a whopping $3 billion….
AstraZeneca inks yet another deal; boosts cancer drug portfolio
AstraZeneca is continuing with its acquisition and deals spree as it inks yet another license agreement and collaboration deal with Inovio Pharmaceuticals. The deal has been inked between AstraZeneca’s MedImmune and Inovio…
Cool kids popular in school may experience problems as adults
Being ‘cool’ at school may not always be a good thing, researchers have warned, as study has shown that popular kids often experience problems as adults. A University of Virginia study has…
3D image of malaria ‘conductor’ Plasmepsin V paves way for new class of drugs
A new discovery involving a malarial protein dubbed Plasmepsin V could pave way for development of a new class of antimalarial drugs, researchers have revealed. Scientists at Melbourne’s Walter and Eliza Hall…
AstraZeneca to divest Caprelsa; inks $300 million deal with Sanofi’s Genzyme
In a major divestment move AstraZeneca has decided to transfer the global rights to sell and develop Caprelsa to Genzyme – a deal that will see the former net $300 million. Caprelsa…
Cholesterol drug Praluent lands US FDA approval
The US Food and Drug Administration (FDA) has stamped its seal of approval on the first cholesterol-lowering treatment approved in a new class of drugs known as proprotein convertase subtilisin kexin type…
Diabetes drug said to have preventative effect against Parkinson’s disease
A class of drugs – glitazone – which is used to treat diabetes may also find use in preventing Parkinson’s disease, a new study has revealed. Osiglitazone or pioglitazone are the two…
57.1m antidepressants, 1.7m erectile dysfunction drugs prescribed in UK last year
According to the latest report on prescription drugs by Health and Social Care Information Centre (HSCIC), UK there has been a whopping 50 per cent increase in the number of items prescribed…
US FDA approves cystic fibrosis drug
In a landmark development, the first cystic fibrosis drug – Orkambi (lumacaftor 200 mg/ivacaftor 125 mg) – capable of treating the cause of the disease in people who have two copies of…
Immunocore, Lilly ink immunotherapy-based clinical trial pact for melanoma
Immunocore Limited and Eli Lilly and Company have entered into a agreement under which they will setup an immunotherapy-based clinical trial collaboration to explore both the company’s melanoma drugs. The clinical trials…
Fighting opioid addiction problem? Tamper-resistant drugs not the key say experts
Opioid addiction is a huge problem in a number of countries including US and Canada and to fight this issue governments in both the countries have been promoting tamper-resistant drugs. However, experts…